• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Archives for S

Malaria Cure

August 30, 2012 By Malaria Q&A Leave a Comment

QUESTION What medicine is good for curing malaria? ANSWER There are lots of different types of medication which are effective against malaria. However, for uncomplicated, unsevere cases, the World Health Organization (WHO) recommends using a type of medication called artemisinin-based combination therapy, or ACT. Again, there are many types of ACTs, so the name may vary depending on what … [Read more...]

Filed Under: Malaria Q&A Tagged With: ACT, Alu, artemether, artemsinin-based combination therapy, Cerebral Malaria, coma, lumefantrine, S, seizure

Why not create a vaccine for malaria?

March 12, 2012 By Malaria Q&A Leave a Comment

QUESTION Why not create a vaccine for malaria? ANSWER There are many teams of scientists working hard to try to produce a malaria vaccine. In fact, only last year, the preliminary results of a vaccine trial were published. The vaccine, called RTS,S, has been produced by GlaxoSmithKline and is in the midst of Phase III trials in Africa. The preliminary results showed approximately a … [Read more...]

Filed Under: Malaria Q&A Tagged With: Clinical Trials, financial resources, GlaxoSmithKline, Malaria Vaccine Initiative, morbidity, PATH, pharmaceutical companies, RTS, S, severe malaria, vaccine, vaccine testing

Malaria Vaccine Research

March 9, 2012 By Malaria Q&A Leave a Comment

QUESTION Is there any research to produce anti malaria vaccine, if not, why? ANSWER There are many teams of scientists working hard to try to produce a malaria vaccine. In fact, only last year, the preliminary results of a vaccine trial were published. The vaccine, called RTS,S, has been produced by GlaxoSmithKline and is in the midst of Phase III trials in Africa. The preliminary … [Read more...]

Filed Under: Malaria Q&A Tagged With: GlaxoSmithKline, immune response variation, Malaria Control, malaria research, Malaria Vaccine Initiative, PATH, Phase III trial, Plasmodium, RTS, S, strain variation, vaccine

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2023 Malaria.com ยท Log in